肝门部胆管癌51例的外科治疗  

Surgical Treatment of 51 Cases with Hilar Bile Duct Carcinoma

作　　者：陆立[1] 郝志强[1] 谭振刚[1] 栾晓丹[1] 

机构地区：[1]解放军第230医院普外,辽宁丹东118000

出　　处：《临床军医杂志》2007年第4期522-524,共3页Clinical Journal of Medical Officers

摘　　要：目的探讨肝门部胆管癌的外科治疗方法和效果。方法对经手术和病理检查确定诊断的肝门部胆管癌51例的临床特征、手术方式和随访结果进行回顾性分析。结果肿瘤切除17例,其中根治性切除7例,姑息性切除10例。胆肠吻合15例,单纯探查活检6例,胆道支架置入13例。根治性切除组1,3,5年生存率分别为71%,42%和28%。姑息性切除、胆肠吻合和胆道支架置入组1年生存率分别为20%,0%和31%。结论应力争进行唯一能治愈肝门部胆管癌的根治性切除。如无法根治切除,以胆道支架置入为首选治疗方法。Objective To evaluate the method of surgical treatment to hilar bile duct carcinoma and its effect. Methods The clinicopathological variables and the follow-up data of 51 patients with hilar bile duct carcinoma were retrospectively analyzed. Results Resection was performed in 17 patients （radical resection in 7, paUiative resection in 10） , choledochojejunostomy in 15, laparotomy in 6 and stent placement in 13. The 1, 3, 5-year survival rate of the patients treated with radical resection was 71% , 42% and 28% , respectively. The 1-year survival rate of those treated with palliative resection, choledochojejunostomy and stent placement was 20%, 0% and 31% , respectively. Conclusion Radical resection is the first choice for hilar bile duct carcinoma. The biliary stent placement is the primary treatment when radical resection fails.

关 键 词：胆管肿瘤 胆道外科手术 腺癌 

分 类 号：R735.8[医药卫生—肿瘤]